Literature DB >> 30061192

Diagnostic performance of PCR assays for the diagnosis of neurosyphilis: a systematic review.

Michael Marks1,2, David Lawrence3, Christian Kositz3, David Mabey3,2.   

Abstract

INTRODUCTION: Syphilis continues to be a major public health problem and the recent resurgence in syphilis in high-income settings has seen an accompanying increase in cases of neurosyphilis. While the introduction of PCR has had a significant impact on the diagnosis of early syphilis, cerebrospinal fluid (CSF) serological assays remain the most commonly used tests to diagnosis neurosyphilis. We reviewed data on the performance of CSF-PCR for the diagnosis of neurosyphilis.
METHODS: We searched Pubmed, Medline, EMBASE and the grey literature for references on PCR in neurosyphilis. We calculated the sensitivity and specificity of PCR compared with reference testing for the diagnosis of neurosyphilis.
RESULTS: We identified 66 articles of which seven met the study inclusion criteria. The sensitivity of PCR for definite neurosyphilis varied between 40% and 70% and specificity between 60% and 100% across the studies. The most commonly used PCR assay targeted Tp47 which had an overall sensitivity of 68% and a specificity of 91.9%. DISCUSSION: The sensitivity of PCR was low compared with CSF-serological assays but the challenges of evaluating a diagnostic test in the absence of a clear gold standard make definitive interpretation challenging. Most studies were small and not adequately powered highlighting the need for multicentre, multicountry trials to provide adequate statistical power in evaluations of new tests the diagnosis of neurosyphilis. © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Keywords:  PCR; neurology; serology; syphilis

Mesh:

Year:  2018        PMID: 30061192     DOI: 10.1136/sextrans-2018-053666

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  6 in total

1.  Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.

Authors:  Christina M Marra
Journal:  Sex Transm Dis       Date:  2021-08-01       Impact factor: 3.868

2.  Intrathecal Synthesis Index of Specific Anti-Treponema IgG: a New Tool for the Diagnosis of Neurosyphilis.

Authors:  Chloé Alberto; Christine Deffert; Nathalie Lambeng; Gautier Breville; Angèle Gayet-Ageron; Patrice Lalive; Laurence Toutous Trellu; Lionel Fontao
Journal:  Microbiol Spectr       Date:  2022-02-09

3.  Asymptomatic Neurosyphilis in HIV infected patients at a Brazilian HIV and AIDS specialized service: a cross sectional study.

Authors:  Cláudio Queniti Hirai; Deborah de Castro Moreira; Danielle Cristina Tita Granzotto; Eniuce Menezes de Souza; Jorge Juarez Vieira Teixeira; Dennis Armando Bertolini
Journal:  Rev Soc Bras Med Trop       Date:  2022-02-25       Impact factor: 1.581

4.  Spinal Syphilitic Gumma: A Rare Presentation of an Old Disease.

Authors:  Dominic Worku; Angela Houston; Catherine Cosgrove; Laura Byrne
Journal:  Case Rep Infect Dis       Date:  2021-06-02

5.  Diagnostic tools for neurosyphilis: a systematic review.

Authors:  Gustavo Henrique Pereira Boog; João Vitor Ziroldo Lopes; João Vitor Mahler; Marina Solti; Lucas Tokio Kawahara; Andre Kakinoki Teng; João Victor Taba Munhoz; Anna S Levin
Journal:  BMC Infect Dis       Date:  2021-06-14       Impact factor: 3.090

Review 6.  Diagnostic Testing in Central Nervous System Infection.

Authors:  Sanjat Kanjilal; Tracey A Cho; Anne Piantadosi
Journal:  Semin Neurol       Date:  2019-08-02       Impact factor: 3.420

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.